Non-inferiority efficacy trial of risperidone long-acting injection vs. olanzapine tablets

被引：0
|
作者：
Rabinowitz, J [1 ]
Khan, A [1 ]
Augustyns, I [1 ]
Ingham, M [1 ]
机构：
[1] Bar Ilan Univ, IL-52100 Ramat Gan, Israel
来源：
SCHIZOPHRENIA RESEARCH | 2006年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：94 / 95
页数：2
相关论文
共 50 条
  • [1] RISPERIDONE LONG-ACTING INJECTION VS. CONVENTIONAL DEPOT INJECTIONS
    Jensen, S. O. W.
    Nielsen, J.
    Friis, R.
    Correll, C. U.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [2] OVERCOMING THE CHALLENGES OF MODELLING SCHIZOPHRENIA: A UK CASE STUDY OF THE COST-EFFECTIVENESS OF OLANZAPINE LONG-ACTING INJECTION VS. RISPERIDONE LONG-ACTING INJECTION
    Carroll, S. M.
    Jemiai, N.
    Moller, J.
    Novick, D.
    VALUE IN HEALTH, 2009, 12 (07) : A350 - A350
  • [3] RISPERIDONE LONG-ACTING INJECTION VS. ORAL RISPERIDONE: ANALYSIS OF RELAPSE AND REHOSPITALIZATION CONTROLLING FOR SWITCHING IN A PRAGMATIC TRIAL
    Schooler, Nina R.
    SCHIZOPHRENIA BULLETIN, 2015, 41 : S333 - S333
  • [4] Comparative efficacy and safety of long-acting risperidone and risperidone oral tablets
    Chue, P
    Eerdekens, M
    Augustyns, I
    Lachaux, B
    Molcan, P
    Eriksson, L
    Pretorius, H
    David, AS
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 (01) : 111 - 117
  • [5] Risperidone Long-acting Injection vs. Oral Risperidone: A Secondary Analysis of Relapse and Rehospitalization Controlling for Switching in a Pragmatic Trial
    Schooler, Nina R.
    Gopinath, Srinath
    Weedon, Jeremy
    Buckley, Peter F.
    Goff, Donald C.
    Kopelowicz, Alexander
    Lauriello, John
    Manshreck, Theo
    Mendelowitz, Alan J.
    Miller, Del D.
    Wilson, Daniel R.
    Kane, John M.
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S354 - S355
  • [6] Long-acting risperidone injection
    Love, RC
    Conley, RJ
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (17) : 1792 - 1800
  • [7] COST-EFFECTIVENESS ANALYSIS OF OLANZAPINE LONG-ACTING INJECTION COMPARED WITH RISPERIDONE LONG-ACTING INJECTION IN THE TREATMENT OF SCHIZOPHRENIA IN NORWAY
    Carroll, S. M.
    Jemiai, N.
    Suter, B.
    O'Donohoe, P.
    Skjoldborg, U.
    Moller, J.
    Kleivenes, O. K.
    Novick, D.
    VALUE IN HEALTH, 2009, 12 (07) : A358 - A358
  • [8] AN OPEN, RANDOMIZED, CONTROLLED COMPARISON OF LONG-ACTING INJECTABLE RISPERIDONE VS. ORAL OLANZAPINE IN SCHIZOPHRENIA & SCHIZOAFFECTIVE DISORDER
    Keks, Nicholas A.
    SCHIZOPHRENIA RESEARCH, 2012, 136 : S5 - S5
  • [9] A NON-INFERIORITY TRIAL OF BBTI VS. CBTI: PRELIMINARY RESULTS
    Bramoweth, Adam D.
    Lederer, Lisa G.
    Youk, Ada O.
    Germain, Anne
    Chinman, Matthew J.
    SLEEP, 2019, 42
  • [10] Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia
    Singh, Dhiren
    O'Connor, Daniel W.
    CLINICAL INTERVENTIONS IN AGING, 2009, 4 : 351 - 355
12345